(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUROPATHY REVERSAL METHOD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEUROPATHY REVERSAL METHOD

ST13

US500000088948058

Class

44

Filing

88948058

Registration

6382488

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

06/09/2026

Trademark type

Word

Nice classes

44

Filing date

06/04/2020

Registration date

06/08/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/08/2021

Last transaction

06/09/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

2020-01-00

First use in commerce

2020-01-00

Drawing code

4

Owner type

21

Owner location

Carrollton, TX, US

Examiner

MCCARTHY, BRIDGET ANN

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

B. L. (pessoa física)

Representatives

Christopher J. Day Day Law Firm

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical treatment of neuropathy

Publications

History of USPTO decisions and trademark events.

24 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/08/2026

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

06/08/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/03/2021

ALIE

ASSIGNED TO LIE

05/03/2021

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

04/30/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

04/30/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/30/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

04/30/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/30/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

04/28/2021

IUAA

USE AMENDMENT ACCEPTED

04/27/2021

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

04/10/2021

IUAF

USE AMENDMENT FILED

04/10/2021

EAAU

TEAS AMENDMENT OF USE RECEIVED

04/09/2021

NREV

NOTICE OF REVIVAL - E-MAILED

03/24/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/24/2021

PETG

PETITION TO REVIVE-GRANTED

03/24/2021

PROA

TEAS PETITION TO REVIVE RECEIVED

03/24/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/08/2020

GNRT

NON-FINAL ACTION E-MAILED

09/08/2020

CNRT

NON-FINAL ACTION WRITTEN

09/08/2020

DOCK

ASSIGNED TO EXAMINER

09/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/25/2020

NWAP

NEW APPLICATION ENTERED

06/08/2020

Continuous trademark protection

Get notified about every new filing that threatens NEUROPATHY REVERSAL METHOD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.